Specialty code 183500000X · Fairfield, CA
NPI
1134500473
Since 2015
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1550 Gateway Blvd
Fairfield, CA, 94533
Phone (802) 779-1494
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$490K
2,012 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kimberly A Gordon prescribed most often to Medicare patients was Ozempic (Semaglutide), with 461 prescriptions and refills. In total Kimberly A Gordon wrote 2,012 Medicare prescriptions that cost $490K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 461 | 479 | 65 | $341K |
| Metformin Hcl Er Metformin Hcl | 197 | 624 | 82 | $1,910 |
| Glipizide Generic | 186 | 596 | 75 | $2,258 |
| Atorvastatin Calcium Generic | 176 | 582 | 68 | $2,157 |
| Insulin Glargine-Yfgn Generic | 108 | 320 | 59 | $16K |
| Jardiance Empagliflozin | 98 | 299 | 40 | $54K |
| Humulin N Insulin Nph Human Isophane | 89 | 260 | 42 | $15K |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 82 | 256 | 34 | $2,278 |
| Metformin Hcl Generic | 80 | 258 | 33 | $1,043 |
| Humulin R Insulin Regular, Human | 73 | 212 | 27 | $11K |
| Simvastatin Generic | 51 | 158 | 18 | $557 |
| Pioglitazone Hcl Generic | 38 | 127 | 15 | $517 |
| Lisinopril Generic | 36 | 120 | 17 | $437 |
| Glipizide Er Glipizide | 35 | 112 | 13 | $884 |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 35 | 107 | 18 | $1,080 |
Brand drugs: 927 claims; generic drugs: 925 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kimberly A Gordon were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.